Trust in scientific evidence depends on more than methodological rigor and transparency. In this webinar, Professor Lisa Bero will examine research integrity in systematic reviews, exploring conflicts of interest, the difference between transparency and independence from commercial interests, and the factors that shape our belief in research and its findings.
As part of the Cochrane presents: Stories and ideas from thought leaders in evidence synthesis series, this webinar will offer an opportunity to reconnect with one of the influential voices who has helped shape both Cochrane and the wider evidence-synthesis community. The series invites distinguished contributors to reflect on their personal journeys, share lessons learned from their involvement in advancing evidence synthesis, and explore the ideas, challenges, and opportunities that will shape its future.
The webinar will include a brief presentation, followed by a discussion, allowing attendees to engage directly with Professor Bero, ask questions, and contribute their own perspectives. The conversation and Q&A will be moderated by Ella Flemyng, Head of Editorial Policy and Research Integrity at Cochrane.
Presenter
Lisa Bero, an affiliate professor at the University of Colorado and Senior Research Integrity Editor at Cochrane, is a leader in evidence synthesis, meta-research and studying commercial determinants of health, focusing on tobacco control, pharmaceutical policy, nutrition, chemicals and public health. She is internationally known for her studies on the integrity of research evidence that is used to influence health policy. She is a founding member of the Center to End Corporate Harm at the University of California, San Francisco. She was co-chair of the Cochrane Governing Board from 2014 to 2018. She studies the association of reporting bias, methodological characteristics, funding bias, conflicts of interest, and research integrity problems with the design and outcomes of research.
